Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.
2.

Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.

Birkholz K, Schwenkert M, Kellner C, Gross S, Fey G, Schuler-Thurner B, Schuler G, Schaft N, Dörrie J.

Blood. 2010 Sep 30;116(13):2277-85. doi: 10.1182/blood-2010-02-268425. Epub 2010 Jun 21.

4.

Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells.

Chatterjee B, Smed-Sörensen A, Cohn L, Chalouni C, Vandlen R, Lee BC, Widger J, Keler T, Delamarre L, Mellman I.

Blood. 2012 Sep 6;120(10):2011-20. doi: 10.1182/blood-2012-01-402370. Epub 2012 Jul 12.

5.

The FcgammaRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR gamma-chain.

van Vugt MJ, Kleijmeer MJ, Keler T, Zeelenberg I, van Dijk MA, Leusen JH, Geuze HJ, van de Winkel JG.

Blood. 1999 Jul 15;94(2):808-17.

6.

The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing.

Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, Nussenzweig MC.

Nature. 1995 May 11;375(6527):151-5.

PMID:
7753172
7.

A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells.

Guo M, Gong S, Maric S, Misulovin Z, Pack M, Mahnke K, Nussenzweig MC, Steinman RM.

Hum Immunol. 2000 Aug;61(8):729-38.

PMID:
10980384
8.

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.

Schreibelt G, Klinkenberg LJ, Cruz LJ, Tacken PJ, Tel J, Kreutz M, Adema GJ, Brown GD, Figdor CG, de Vries IJ.

Blood. 2012 Mar 8;119(10):2284-92. doi: 10.1182/blood-2011-08-373944. Epub 2012 Jan 10.

9.

Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane.

Chow A, Toomre D, Garrett W, Mellman I.

Nature. 2002 Aug 29;418(6901):988-94.

PMID:
12198549
10.

Transport of peptide-MHC class II complexes in developing dendritic cells.

Turley SJ, Inaba K, Garrett WS, Ebersold M, Unternaehrer J, Steinman RM, Mellman I.

Science. 2000 Apr 21;288(5465):522-7.

11.

The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.

Inaba K, Turley S, Iyoda T, Yamaide F, Shimoyama S, Reis e Sousa C, Germain RN, Mellman I, Steinman RM.

J Exp Med. 2000 Mar 20;191(6):927-36.

12.

Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.

Burgdorf S, Kautz A, Böhnert V, Knolle PA, Kurts C.

Science. 2007 Apr 27;316(5824):612-6.

13.

Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells.

Tardif V, Riquelme SA, Remy S, Carreño LJ, Cortés CM, Simon T, Hill M, Louvet C, Riedel CA, Blancou P, Bach JM, Chauveau C, Bueno SM, Anegon I, Kalergis AM.

Eur J Immunol. 2013 Nov;43(11):2832-44. doi: 10.1002/eji.201343600. Epub 2013 Aug 21.

14.

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.

Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, Brimnes MK, Moltedo B, Moran TM, Steinman RM.

J Exp Med. 2004 Mar 15;199(6):815-24.

15.

Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule.

Johnson TS, Mahnke K, Storn V, Schönfeld K, Ring S, Nettelbeck DM, Haisma HJ, Le Gall F, Kontermann RE, Enk AH.

Clin Cancer Res. 2008 Dec 15;14(24):8169-77. doi: 10.1158/1078-0432.CCR-08-1474.

16.

The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells.

Wang B, Kuroiwa JM, He LZ, Charalambous A, Keler T, Steinman RM.

Ann N Y Acad Sci. 2009 Sep;1174:6-17. doi: 10.1111/j.1749-6632.2009.04933.x.

17.

Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules.

Ramakrishna V, Treml JF, Vitale L, Connolly JE, O'Neill T, Smith PA, Jones CL, He LZ, Goldstein J, Wallace PK, Keler T, Endres MJ.

J Immunol. 2004 Mar 1;172(5):2845-52.

18.

Expression of human DEC-205 (CD205) multilectin receptor on leukocytes.

Kato M, McDonald KJ, Khan S, Ross IL, Vuckovic S, Chen K, Munster D, MacDonald KP, Hart DN.

Int Immunol. 2006 Jun;18(6):857-69. Epub 2006 Mar 31.

PMID:
16581822
19.

Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.

Niazi KR, Ochoa MT, Sieling PA, Rooke NE, Peter AK, Mollahan P, Dickey M, Rabizadeh S, Rea TH, Modlin RL.

Immunology. 2007 Dec;122(4):522-31. Epub 2007 Jul 16.

20.

Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.

Leung CS, Maurer MA, Meixlsperger S, Lippmann A, Cheong C, Zuo J, Haigh TA, Taylor GS, Münz C.

Blood. 2013 Feb 28;121(9):1584-94. doi: 10.1182/blood-2012-08-450775. Epub 2013 Jan 7.

Supplemental Content

Support Center